RxDoctor Payments DataLook up a doctor →

Michael Schindel, MD

Family Medicine · Lakewood, CONPI 1881778256

Payments from drug & device makers

$16,186in general payments, 2019–2025

Across 943 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$1K
  • Amgen$1K
  • Johnson & Johnson$1K
  • Novo Nordisk$779
  • Lilly USA, LLC$758
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)159$2,649
AstraZeneca62$1,234
Amgen(2 entities)64$1,038
Johnson & Johnson61$1,010
Novo Nordisk53$779
Lilly USA, LLC58$758
GSK44$703
Pfizer53$677
Boehringer Ingelheim39$656
Otsuka America Pharmaceutical, Inc.29$614
Supernus Pharmaceuticals, Inc.4$525
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC26$372
Merck23$350
Esperion Therapeutics, Inc.18$336
Gilead11$286
Viiv Healthcare Company16$267
Novartis13$241
Bayer13$232
Astellas Pharma US Inc12$225
Eisai Inc.16$225
Adlon Therapeutics L.p.14$213
Ironshore Pharmaceuticals Inc.4$203
Amneal Pharmaceuticals LLC10$163
Biohaven Pharmaceutical Holding Company Ltd.13$142
Amarin Pharma, Inc.9$141
Sanofi-aventis U.S. LLC9$139
Takeda Pharmaceuticals U.S.A., Inc.7$134
Kowa Pharmaceuticals America, Inc.7$112
Boston Scientific5$112
Corium, LLC5$96
Optinose US, Inc.4$90
Idorsia Pharmaceuticals US Inc4$78
Biohaven Pharmaceuticals, Inc.4$76
Abiomed2$71
Valeritas, Inc.4$70
Paratek Pharmaceuticals, Inc.4$68
E.r. Squibb & Sons, L.L.C.4$68
Seqirus USA Inc3$65
Exact Sciences3$64
Sumitomo Pharma America, Inc.3$63
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$56
Lundbeck LLC3$55
Teva Pharmaceuticals USA, Inc.2$54
Hologic Sales And Service, LLC4$50
Nestle Healthcare Nutrition Inc.3$48
Mannkind Corporation3$45
Dexcom, Inc.3$45
Vertical Pharmaceuticals, LLC2$43
Abbott2$38
Shire North American Group Inc3$34
Aimmune Therapeutics, Inc.2$32
Genentech USA, Inc.2$32
Lucid Diagnostics Inc.2$28
Hikma Pharmaceuticals USA2$27
Phathom Pharmaceuticals, Inc.1$24
Sanofi Pasteur Inc.1$23
ANI Pharmaceuticals, Inc.1$20
Organogenesis Inc.1$18
Axsome Therapeutics, Inc.1$18
Vertiflex, Inc.1$17

How this compares

$16,186 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado →

Medicare billing

Part B allowed, 2024
$55,116
Medicare patients
114
Services billed
912

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Lakewood

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →